A Randomized Controlled Study of Digitalized Cognitive-behavioral Intervention for Childhood Anxiety

Sponsor
University of Turku (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03310489
Collaborator
(none)
420
1
2
37.3
11.3

Study Details

Study Description

Brief Summary

The aim of the study is to evaluate the effectiveness of a digitalized cognitive-behavioral treatment for anxiety among school aged children. The participants are screened from the general population, as a part of the routine school health care check-ups. Half of the children with anxiety will receive the digitalized treatment program, while the other half will receive education about anxiety in internet.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Digitalized cognitive-behavioral intervention for anxiety
  • Behavioral: Psychoeducation about anxiety
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
420 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Digitalized Cognitive-behavioral Intervention for Anxiety Among School Children. A Randomized Controlled Study
Actual Study Start Date :
Oct 24, 2017
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Digitalized cognitive-behavioral intervention

Behavioral: Digitalized cognitive-behavioral intervention for anxiety
An internet-based CBT, including telephone coaching

Active Comparator: Psychoeducation about anxiety

Behavioral: Psychoeducation about anxiety
Psychoeducative material about anxiety in internet

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline to 6 months follow up; the Screen for Child Anxiety Related Disorders - child and parent reports [Change from baseline to 6 months follow up; symptoms during the last three months]

    Comprises of 41 items assessing symptoms of general anxiety, separation anxiety, panic disorder, social anxiety, and school phobia; scoring 0-82 (higher score meaning more symptoms)

Secondary Outcome Measures

  1. Change from Baseline to 6 months follow up; the Child Anxiety Impact Scale - child and parent reports [Change from baseline to 6 months follow up; impact of anxiety during the last month]

    Comprises of 27 items assessing the impact of anxiety on the daily life of the children at home, school and with friends; scoring 0-81 (higher score meaning higher impact of anxiety)

  2. Change from Baseline to 6 months follow up (in the Intervention group); the Development and Well-Being Assessment - child and parent reports [Change from baseline to 6 months follow up; varying time windows for different diagnoses]

    A diagnostic interview to assess anxiety disorders among 2-17-year-old children

  3. Change from Baseline to 6 months follow up; the Revised Children Quality of Life - Questionnaire - child and parent reports [Change from baseline to 6 months follow up; QoL during the last week]

    Comprises of 24 items assessing the health-related quality of life divided into six subscales: physical, psychological, self-esteem, family, social life, and school; scoring 24-96 (higher score meaning higher QoL)

  4. Change from Baseline to 6 months follow up; the Child Depression inventory - child report [Change from baseline to 6 months follow up; symptoms during the last two weeks]

    Comprises of 28 items assessing the child's depressive symptoms; scoring 0-54 (higher score meaning more symptoms)

  5. Change from Baseline to 6 months follow up; the Strengths and Difficulties Questionnaire, extended version - parent report [Change from baseline to 6 months follow up; symptoms during the last six months]

    Comprises of 25 items assessing the child's psychiatric symptoms and positive attributes, and an impact supplement; scoring 0-40 (prosocial scale is not included in the total score) (higher score meaning more problems)

  6. Change from Baseline to 6 months follow up of the relations with peers and school (not a standardized scale) [Change from baseline to 6 months follow up]

    Experience of being bullied (traditional and cyberbullying), and feelings about school and teachers

  7. Change from Baseline to 6 months follow up; the Brief resilience scale - parent report (parental resilience) [Change from baseline to 6 months follow up; experience of the current resilience]

    Comprises of six items assessing resilience; scoring 6-36 (higher score meaning higher resilience)

  8. Change from Baseline to 6 months follow up; the Depression Anxiety and Stress Scale Short Form - parent report (parental depression, anxiety and stress) [Change from baseline to 6 months follow up; symptoms during the last week]

    Comprises of 21 items assessing parental depression, anxiety and stress; scoring 0-63 (higher score meaning more symptoms)

  9. Change from Baseline to 6 months follow up; the Customised Client Receipt Inventory Questionnaire - parent report [Change from baseline to 6 months follow up; service use during the last six months]

    Assesses the child's use of school support services, and social and health care services

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Scoring ≥22 on SCARED
Exclusion Criteria:
  • no access to internet

  • insufficient language (Finnish until summer 2019, Finnish and Swedish from autumn 2019 onwards, when also Swedish version of the intervention was available) skills

  • visual or hearing impairment that hinders the use of the program

  • the child's mental retardation, autism spectrum disorder, suicidal intentions or severe mental disorder

  • the child's psychotherapy (ongoing or starting within 6 months)

  • the child's medication (for anxiety) started / changed within 2 months

  • current involvement with child protection services (i.e., removal of child custody, investigation of child abuse or neglect)

  • parent's severe psychiatric / somatic disease or other reason that hinders the parent to actively participate in the program

Contacts and Locations

Locations

Site City State Country Postal Code
1 Child Psychiatric Research Center, University of Turku Turku Finland 20500

Sponsors and Collaborators

  • University of Turku

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andre Sourander, Professor (child psychiatry), University of Turku
ClinicalTrials.gov Identifier:
NCT03310489
Other Study ID Numbers:
  • ANXIETY-2017
First Posted:
Oct 16, 2017
Last Update Posted:
Sep 10, 2020
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 10, 2020